Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice

Autor: Martha D. Wilson, Allison L. McDaniel, Xavier Collet, Ramesh Shah, Kanwardeep S. Bura, Caleb C. Lord, Janet K. Sawyer, Uwe J. F. Tietge, Arne Dikkers, J. Mark Brown, Ryan E. Temel, Matthew A. Davis, Jun Zhang, Gwyn Thomas, Lawrence L. Rudel, Stephanie M. Marshall, Manya Warrier

Publikováno v: Journal of Lipid Research, Vol 54, Iss 6, Pp 1567-1577 (2013)
Journal of Lipid Research, 54(6), 1567-1577. AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC

Reverse cholesterol transport (RCT) can proceed through the classic hepatobiliary route or through the non-biliary transintestinal cholesterol efflux (TICE) pathway. Scavenger receptor class B type I (SR-BI) plays a critical role in the classic hepat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a590a714dafcf7eaccfc261301132c75
http://www.sciencedirect.com/science/article/pii/S0022227520357138

Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain

Autor: Daniel Zamanillo, Thomas Guegan, Rafael Maldonado, A. S. Bura, José Miguel Vela

Publikováno v: European Journal of Pain. 17:832-843

Background The treatment of neuropathic pain is unsatisfactory at the present moment and the sigma 1 receptor has been identified as a new potential target for neuropathic pain. The aim of this study was to use an operant self-administration model to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d1caa12458ad5316c90b56fff8c621f
https://doi.org/10.1002/j.1532-2149.2012.00251.x

Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain

Autor: A S, Bura, T, Guegan, D, Zamanillo, J M, Vela, R, Maldonado

Publikováno v: European journal of pain (London, England). 17(6)

The treatment of neuropathic pain is unsatisfactory at the present moment and the sigma 1 receptor has been identified as a new potential target for neuropathic pain. The aim of this study was to use an operant self-administration model to reveal the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::53129d235aee12106ba101e270e13e56
https://pubmed.ncbi.nlm.nih.gov/23658072

Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain.

Autor: La Porta C; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University (CEXS-UPF), Barcelona, Spain Department of Experimental and Health Sciences, Pompeu Fabra University (CEXS-UPF), Barcelona, Spain Cell Research Group on Inflammation and Cartilage, Hospital del Mar Medical Research Institute, Rheumatology Department, Hospital del Mar, Barcelona, Spain Human Pharmacology and Clinical Neurosciences Research Group, Neuroscience Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain Department of Pharmacology, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Alicante, Spain CIBER de Fisiopatología Obesidad y Nutrición, Santiago de Compostela, Spain Department of Rheumatology, Universitat Autònoma de Barcelona, Hospital del Mar, Barcelona, Spain (A. S. Bura is now with the Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, München, Germany)., Bura SA, Llorente-Onaindia J, Pastor A, Navarrete F, García-Gutiérrez MS, De la Torre R, Manzanares J, Monfort J, Maldonado R

Publikováno v: Pain [Pain] 2015 Oct; Vol. 156 (10), pp. 2001-2012.